SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Takahashi N., Nishida H., Ino M., Sakata Y., Sakuma I., Takeda Y. (1995) A new exanthematous disease in newborn infants. Acta Neonat Jpn 31: 37177 (in Japanese).
  • 2
    Takahashi N., Nishida H. (1997) A new exanthematous disease with thrombocytopenia in newborn infants. Letter Arch Dis Child 77: F79.
  • 3
    Sakata Y., Hamada T., Kabe K., Nishida H., Miwa K., Endou M., Igarashi H., Uchiyama T. (1997) Exanthema of the newborn related to toxic shock syndrome toxin-1 (TSST-1). Jpn J Obstet Gynecol Neonat Hematol 7: 14650.
  • 4
    Kotzin B., Leung D.Y.M., Kappler J., Marrack P. (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99166.
  • 5
    Uchiyama T., Yan X-J., Imanishi K., Yagi J. (1994) Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol 38: 24556.
  • 6
    Uchiyama T., Imanishi K., Miyoshi-Akiyama T., Kato H. (2006) Staphylococcal superantigens and diseases caused by them. In: Alouf J.E., Popoff M.R., eds. The Comprehensive Sourcebook of Bacterial Protein Toxins, 3rd edn. New York: Elsevier, pp. 83043.
  • 7
    Todd J., Fishaut M., Kapral F., Welch T. (1978) Toxic shock syndrome associated with phage-group-I staphylococci. Lancet ii: 11168.
  • 8
    Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., Davis J.P. (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 101721.
  • 9
    Schlievert P.M., Shands K.N., Dan B.B., Schmid G.P., Nishimura R.D. (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock-syndrome. J Infect Dis 143: 50916.
  • 10
    White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. (1989) The Vβ-specific staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 2735.
  • 11
    Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. (1998) Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351: 16149.
  • 12
    van der Mee-Marquet N., Lina G., Quentin R., Yaouanc-Lapalle H., Fie‘vre C., Takahashi N., Etienne J. (2003) Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists. J Clin Microbiol 41: 48834.
  • 13
    Nakano K., Hu D-L., Tsuji T., Kawagishi M., Torii K., Hasegawa T., Iinuma Y., Ohta M. (2002) An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit. Microbiol Immunol 46: 27784.
  • 14
    Takahashi N. (2003) Neonatal toxic shock syndrome-like exanthematous disease (NTED). Pediatr Int 45: 2337.
  • 15
    Kappler J., Kotzin B., Herron L., Gelfand E.W., Bigler R.D., Boylston A., Carrel S., Posnett D.N., Choi Y., Marrack P. (1989) Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244: 8113.
  • 16
    Choi Y., Kotzin B., Herron L., Callahan J., Marrack P. (1989) Interaction of Staphylococcus aureus toxin “Superantigens” with human T cells. Proc Natl Acad Sci USA 86: 89415.
  • 17
    Takahashi N., Imanishi K., Nishida H., Uchiyama T. (1995) Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 155: 52139.
  • 18
    Takahashi N., Kato H., Imanishi K., Miwa K., Yamanami S., Nishida H., Uchiyama T. (2000) Immunopathophysiological aspects of an emerging infectious disease induced by a bacterial superantigen. J Clin Invest 106: 140915.
  • 19
    Takahashi N., Kato H., Imanishi K., Ohki T., Uehara R., Momoi M.Y., Nishida H., Uchiyama T. (2009) Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen. Microbiol Immunol 53: 52430.
  • 20
    Kato H., Takahashi N., Arimura Y., Imanishi K., Nishida H., Uchiyama T. (2002) The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J Infect Chemother 8: 1114.
  • 21
    Takahashi N., Uehara R., Nishida H., Sakuma I., Yamasaki C., Takahashi K., Honma Y., Momoi M.Y., Uchiyama T. (2009) Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect 59: 194200.
  • 22
    Takahashi N., Yada Y., Honma Y., Sakuma I., Nishida H. (2003) Two cases of neonatal TSS-like exanthematous disease (NTED) complicated with severe airway damage. Jpn J Obstet Neonatal Hematol 13: S6566 (Japanese).
  • 23
    Kikuchi K., Takahashi N., Piao C., Totsuka K., Nishida H., Uchiyama T. (2003) Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol 41: 30016.
  • 24
    Takahashi N. (2003) Current status of MRSA infections in neonatal medicine in Japan. Pediatr Int 45: 2212.
  • 25
    Aires de Sousa de Lencastre M., Santos H., Sanches I., Kikuchi K., Totsuka K., Tomasz A. (2000) Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in hospitals in New York City and in a hospital in Tokyo, Japan. Microb Drug Resist 6: 2538.
  • 26
    Gbaguidi-Haore H., Thouverez M., Couetdic G., Cholley P., Talon D., Bertand X. (2009) Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing methicillin-resistant Staphylococcus aureus in a French university hospital. J Med Microbiol 58: 133742.
  • 27
    Takahashi N., Choi S., Yada Y., Honma Y., Momoi M., Nishida H. (2005) A nationwide survey of MRSA carriage in neonatal intensive care units in Japan. J Jpn Pediatr Soc 109: 100914 (Japanese).
  • 28
    Aoyagi J., Takahashi N., Yada Y., Koike Y., Kobayashi M., Honma Y., Morisawa Y., Momoi M. (2008) Portable alcohol-based disinfectant handrub and unselective application of nasal mupirocin ointment for prevention of methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. J Jpn Soc Perinatal Neonatal Med 44: 114751 (in Japanese).
  • 29
    Parsonnet J., Goering R.V., Hansmann M.A., Jones M.B., Ohtagaki K., Davis C.C., Totsuka K. (2008) Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. J Clin Microbiol 46: 27318.
  • 30
    Verkaik N.J., Dauwalder O., Antri K., Boubekri I., Vogel C.P., Badiou C., Bes M., Vandenesch F., Tazir M., Hooijkaas H., Verbrugh H.A., van Belkum A., Etienne J., Lina G., Ramdani-Bouguessa N., van Wamel W.J. (2010) Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 50: 618.
  • 31
    Takahashi N., Hattori M., Miwa K., Nishida H. (2006) Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants’ cord blood. Am J Perinatol 23: 41320.
  • 32
    Bergdoll M.S. (1987) Staphylococcal toxin antibody titers in human. Clin Immunol Newsl 8: 14952.
  • 33
    Bavari S., Dyas B., Ulrich R. (1996) Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J Infect Dis 174: 33845.
  • 34
    Rasigade J-P., Thomas D., Perpoint T., Peyramond D., Chidiac C., Etienne J., Vandenesch F., Lina G., Ferry T. (2011) T-cell response to superantigen restimulation during menstrual toxic shock syndrome. FEMS Immunol Med Microbiol 62: 36871.
  • 35
    Takahashi N., Hasegawa H., Komiyama M., Ohki T., Yada Y., Koike Y., Kawamata R., Honma Y., Momoi M. (2009) Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease. Cytokine 45: 3943.
  • 36
    Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B. (1990) Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 172: 9814.
  • 37
    Matsuda Y., Kato H., Yamada R., Okano H., Ohta H., Imanishi K., Kikuchi K., Totsuka K., Uchiyama T. (2003) Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T cell receptor Vβ2-positive T cells. Emerg Infect Dis 9: 3879.
  • 38
    Ferry T., Thomas D., Bouchut J.C., Lina G., Vasselon-Raina M., Dauwalder O., Gillet Y., Vandenesch F., Floret D., Etienne J. (2008) Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy. Pediatr Infect Dis J 27: 2747.
  • 39
    Dateki S., Kumamoto T., Takayanagi T., Ohki T., Takahashi N., Moriuchi H. (2009) Differential T-cell response in a young child and neonates with toxic shock syndrome. Pediatr Int 51: 1556.
  • 40
    Sato A., Nakano Y., Inaba A., Fukushima R., Ito M., Shiga K., Sugai K., Sakon T., Tateishi I., Funabiki T. (2007) Toxic shock syndrome toxin-1-mediated exanthematous disease in a burned infant. Pediatr Int 49: 4035.